Try our Advanced Search for more refined results
Intellectual Property
-
April 09, 2025
9th Circ. Won't Restore Competing TM Claims In Vitamin Row
The Ninth Circuit on Wednesday refused to revive competing trademark infringement claims between a pair of vitamin and supplement companies, backing a lower court's finding that neither party was able to prove their case.
-
April 09, 2025
Bristol Myers Beats Pomalyst Antitrust Suit Alleging IP Fraud
A New York federal judge has tossed a proposed antitrust class action accusing Bristol Myers' Celgene subsidiary of fraudulently obtaining patents and filing "sham" infringement lawsuits to block generic versions of its blood-cancer drug Pomalyst, finding that the indirect drug buyer plaintiffs lack standing and haven't plausibly alleged fraud.
-
April 09, 2025
ITC Ends Google Patent Case Against Sonos
The U.S. International Trade Commission has decided to end another investigation into whether Sonos speakers infringe patents issued to Google, finding those patents are invalid.
-
April 09, 2025
2nd Circ. Allows Takeda To Appeal Actos Antitrust Class Cert.
A split Second Circuit will allow Takeda Pharmaceuticals Co. to immediately appeal a New York federal judge's ruling certifying two classes of direct purchasers and end payors in consolidated antitrust actions accusing the company of unlawfully inflating the price of its diabetes treatment Actos by delaying the entry of generic alternatives.
-
April 09, 2025
Disney Doesn't Deserve $5.7M Fee In 'Moana' Suit, Artist Says
Disney doesn't deserve $5.7 million in fees for beating an animator's copyright suit accusing it of ripping off his Polynesian adventure story to create "Moana," the plaintiff said Tuesday, arguing his case wasn't frivolous, considering the California federal judge found multiple times that sufficient similarity existed between the works.
-
April 09, 2025
Justices Urged To Look At Fed. Circ. Ax Of $13M IP Verdict
A patent-holding company has asked the U.S. Supreme Court to review a Federal Circuit decision that threw out a $13 million jury verdict against NCR Corp. in a suit accusing it of infringing two payment processing patents.
-
April 09, 2025
Dropbox Can See Case Funding Details In IP Row, Court Says
A patent owner has to hand over a copy of an agreement it has with a litigation funder as part of its infringement lawsuit against Dropbox over cloud-based file system patents, a federal magistrate judge in California has ruled.
-
April 09, 2025
Fed. Circ. Says 'Highly Descriptive' Voter TMs Not Protectable
The Federal Circuit on Wednesday concluded that the Heritage Alliance's trademarks for "iVoterGuide" and "iVoterGuide.com" are highly descriptive and not protectable, rejecting a challenge to the American Policy Roundtable's use of "iVoters" and "iVoters.com" despite a likelihood of confusion between the organizations' marks.
-
April 09, 2025
Senior PTAB Judge Joins Sterne Kessler's Electronics Team
The Patent Trial and Appeal Board's vice chief administrative patent judge has left her role after more than a decade to join Sterne Kessler Goldstein & Fox PLLC's electronics practice, the firm has announced.
-
April 09, 2025
Ex-Qualcomm Executive Convicted Of $180M Fraud
A federal jury in San Diego has found a former executive at Qualcomm guilty of defrauding the chipmaker by creating a fake company, concealing his connection to it and selling it to Qualcomm for $180 million.
-
April 08, 2025
Jazz Agrees To Pay $145M To Settle Xyrem Antitrust Fight
Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation accusing it of working with its rival Hikma Pharmaceuticals to stave off generic competitors to Jazz's narcolepsy drug Xyrem, the Ireland-based pharmaceutical company revealed Tuesday.
-
April 08, 2025
MrBeast Accuses Ex-Employee Of Stealing Confidential Docs
YouTuber Mr. Beast's media company has hauled a former IT contractor into North Carolina federal court, accusing him of downloading thousands of confidential company documents ahead of his termination — documents the company said have yet to be returned — and leaving behind hidden cameras throughout the company's offices.
-
April 08, 2025
Charles Schwab, Comerica & More Hit With EDTX Patent Suits
At least eight banks and financial institutions were caught up in a wave of patent lawsuits filed Tuesday in the Eastern District of Texas over technology covering a way of securing payment systems from data breaches.
-
April 08, 2025
Ex-Google Engineer Unlikely To Beat AI Trade Secrets Charges
A California federal judge indicated Tuesday that he's unlikely to toss economic espionage charges against an ex-Google engineer accused of stealing artificial intelligence trade secrets to benefit startups in China, but said he "can't shake the feeling" that prosecutors wouldn't have brought the case if it involved a different country.
-
April 08, 2025
Patent Challenges By Dell, SAP Sunk By Upcoming Trials
The Patent Trial and Appeal Board has refused to review several patents challenged in inter partes review petitions filed by Dell, SAP America and others, citing upcoming infringement trials in Texas.
-
April 08, 2025
ITC Won't Rethink NJOY Loss In Vape Patent Case
The U.S. International Trade Commission on Tuesday refused to undo part of a finding that Altria's NJOY brand vaping products infringed a patent owned by rival Juul, leaving fully in place a ban on imports of infringing products.
-
April 08, 2025
Patent Attys Challenge Sanctions In Renesas Litigation
Texas intellectual property lawyer William Ramey III and two other attorneys have pushed back against a California magistrate judge's sanctions against them in patent litigation, saying that the parties never gave the judge the ability to issue sanctions and that a written rebuke would be better.
-
April 08, 2025
ArentFox Schiff Loses Rolling Stones IP Atty To Barton
Music rights heavyweight Ross Charap is moving from his longtime perch at ArentFox Schiff LLP to Barton LLP, bringing with him clients like The Rolling Stones and the estate of international opera star Jessye Norman.
-
April 08, 2025
Houston Atty Asks Court To Back $6.3M Verdict Against Rival
A Houston attorney urged a Texas appellate court Monday to back a $6 million verdict against a rival lawyer he accused of stealing his files in an attempt to recruit clients to file malpractice suits.
-
April 08, 2025
Nokia Says Hisense TVs Rip Off Its Video Tech
Chinese consumer technology firm Hisense was slapped with a patent infringement lawsuit from Nokia Technologies, alleging it sold millions of products that infringe Nokia's video processing innovations while refusing to negotiate a standard licensing agreement.
-
April 08, 2025
Small But Sharp Hurdles Remain To NCAA's NIL Settlement
Nearly a year after the NCAA and hundreds of thousands of athletes agreed on a settlement that would finally give athletes a share of billions of dollars in revenue, enough flaws remain in the agreement — related to roster limits and the rights of future athletes entering the new system — to indefinitely hold off on its final approval.
-
April 08, 2025
Warner Bros. Wants Rights Protected In Film Co. Ch. 11 Sale
Warner Bros. has objected to the proposed Chapter 11 bidding procedures and debtor-in-possession financing of bankrupt Village Roadshow, asking the court to protect its rights to more than 90 films the parties co-produced and keep its cut of the proceeds ahead of other creditors.
-
April 08, 2025
Fed. Circ. Considers Sandoz's Bid To Undo $39M Patent Loss
The Federal Circuit on Tuesday grappled with Sandoz's challenge to a $39 million verdict against it in Allergan's eyelash growth drug patent infringement case, with one judge questioning the generic-drug maker's argument that a decade-old decision involving a similar patent forestalls the current case.
-
April 08, 2025
Pacira Reaches IP Deal Allowing Generic Painkiller In 2030
Pacira BioSciences has agreed to settle a series of patent infringement lawsuits against Fresenius Kabi and other pharmaceutical companies over Pacira's drug Exparel, a long-acting injectable for managing postsurgical pain.
-
April 08, 2025
Judge Preserves Psilocybin Trade Secrets Theft Suit
A Maryland federal judge has denied a British healthcare company's bid to dismiss a lawsuit alleging it stole trade secrets relating to a novel method of treating depression with psilocybin, the active ingredient in psychoactive mushrooms.
Expert Analysis
-
When US Privilege Law Applies To Docs Made Outside The US
As globalization manifests itself in disputes over foreign-created documents, a California federal court’s recent trademark decision illustrates nuances of both U.S. privilege frameworks and foreign evidentiary protections that attorneys must increasingly bear in mind, say attorneys at Hunton.
-
Looking For Patterns In Pharmaceuticals' Use Of AI Patents
Merging data from the U.S. Patent and Trademark Office's artificial intelligence patent dataset and the U.S. Food and Drug Administration's Orange Book sheds light on pharmaceutical patents involving AI technology, as well as trends in the industry's use of this technology, says Kiefer Ahn at NERA.
-
Notable 2024 Trademark Cases And What To Watch In 2025
Emerging disputes between established tech giants and smaller trademark holders promise to test the boundaries of trademark protection in 2025, following a 2024 marked with disputes in areas ranging from cybersquatting to geographic marks, says Danner Kline at Bradley Arant.
-
How A 9th Circ. Identicality Ruling Could Affect AI Cos.
If the Ninth Circuit agrees to settle a district court split over whether the Digital Millennium Copyright Act requires a copy to be identical to an original to support an actionable claim for removing copyright management information, the decision could have important ramifications for artificial intelligence businesses, says Maria Sinatra at Venable.
-
The State Of USPTO Rulemaking At The End Of Vidal's Term
As U.S. Patent and Trademark Office director, Kathi Vidal placed a particular emphasis on formal rulemaking — so as she returns to private practice this week, attorneys at Irell take stock of which of her proposals made it across the finish line, and where the rest stand on the cusp of a new administration.
-
Examining Vidal's Guidance On PTAB Section 315 Time Bar
Last month's decision by outgoing U.S. Patent and Trademark Office Director Kathi Vidal in Luminex v. Signify addresses the Section 315 statutes that preclude institution of inter partes review proceedings after certain civil actions are filed, and is instructive as PTAB panels are likely to follow this approach going forward, says Amanda Wieker at McGuireWoods.
-
What A Motorcycle IP Case Says About Parallel Int'l Litigation
A Texas federal court recently rejected an electric motorcycle manufacturer's attempt to dismiss a design patent suit in the U.S. and limit the litigation to China, illustrating the challenges in trying to counter a parallel litigation strategy, say attorneys at King & Wood.
-
What 2024 Trends In Marketing, Comms Hiring Mean For 2025
The state of hiring in legal industry marketing, business development and communications over the past 12 months was marked by a number of trends — from changes in the C-suite to lateral move challenges — providing clues for what’s to come in the year ahead, says Ben Curle at Ambition.
-
Navigating The Minefield Of Patenting AI-Generated Inventions
For businesses and individuals trying to patent inventions partially developed with assistance from artificial intelligence — like software that's been coded by AI — recordkeeping and diligent documentation are of paramount importance when seeking patent protection, says Robert Plotkin at Blueshift IP.
-
How Attorneys Can Master The Art Of Eye Contact At Trial
As a growing body of research confirms that eye contact facilitates communication and influences others, attorneys should follow a few pointers to maximize the power of eye contact during voir dire, witness preparation, direct examination and cross-examination, says trial consultant Noelle Nelson.
-
Series
Group Running Makes Me A Better Lawyer
The combination of physical fitness and community connection derived from running with a group of business leaders has, among other things, helped me to stay grounded, improve my communication skills, and develop a deeper empathy for clients and colleagues, says Jessica Shpall Rosen at Greenwald Doherty.
-
7th Circ. Ruling Muddies Split On Trade Secret Damages
The Seventh Circuit's recent endorsement in Motorola v. Hytera of a Second Circuit limit on avoided-cost damages under the Defend Trade Secrets Act contradicts even its own precedents, and will further confuse the scope of a developing circuit conflict that the U.S. Supreme Court has already twice declined to resolve, says Jordan Rice at MoloLamken.
-
Opinion
6 Changes I Would Make If I Ran A Law School
Reuben Guttman at Guttman Buschner identifies several key issues plaguing law schools and discusses potential solutions, such as opting out of the rankings game and mandating courses in basic writing skills.
-
Nutraceutical Patent Insights As Market Heats Up
Companies entering the expanding nutraceutical market and seeking patents to protect their innovations should evaluate successful nutraceutical claim language and common patent challenges in this field, say attorneys at Sterne Kessler.
-
Firms Still Have The Edge In Lateral Hiring, But Buyer Beware
Partner mobility data suggests that the third quarter of this year continued to be a buyer’s market, with the average candidate demanding less compensation for a larger book of business — but moving into the fourth quarter, firms should slow down their hiring process to minimize risks, say officers at Decipher Investigative Intelligence.